Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Expert Review of Clinical Immunology
JournalCitation impact & published research
Expert Review of Clinical Immunology is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,491 works, 55,668 citations and an h-index of 94.
2,491
Works
55,668
Citations
94
h-index
IDs:OpenAlex
What are the most-cited papers on Expert Review of Clinical Immunology?
ScholarIQmost cited works
Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature
Bart J. F. van den Bemt, Hanneke Zwikker, Cornelia HM van den Ende
Expert Review of Clinical Immunology. 2012321 CitationsOPEN ACCESS
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future
Daniela Pugliese, Carla Felice, Alfredo Papa, Antonio Gasbarrini, Gian Lodovico Rapaccini, Luisa Guidi, Alessandro Armuzzi
Expert Review of Clinical Immunology. 2016118 Citations
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics
Ying‐Ming Chiu, Der‐Yuan Chen
Expert Review of Clinical Immunology. 2019112 Citations
Systemic lupus erythematosus and risk of infection
Megan R.W. Barber, Ann E. Clarke
Expert Review of Clinical Immunology. 2020111 Citations
The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review
Saifuddin Kharawala, Amanda Golembesky, Rhonda L. Bohn, Dirk Eßer
Expert Review of Clinical Immunology. 2020102 CitationsOPEN ACCESS
Related on ScholarIQ
Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature
Paper
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future
Paper
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics
Paper
Systemic lupus erythematosus and risk of infection
Paper
The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review
Paper
Biosimilars for the management of rheumatoid arthritis: economic considerations
Paper